We investigated the effectiveness of imiquimod 5% cream, a topical immune-response modulator, for the treatment of this condition. Fifty-two patients with grade 2 or 3 vulvar intraepithelial ...

Imiquimod 5% cream has shown promise as a treatment for superficial basal cell carcinomas and, in pilot studies, for actinic keratoses (AKs). In this manufacturer-supported, randomized, double ...

The research is still at an early stage, but Leung and colleagues have shown that use of the cream imiquimod, a treatment for some skin cancers and warts, can stop scar formation in mice.

Five years after treatment, results showed a freedom from treatment failure rate of 77.8% among the superficial curettage plus imiquimod group. The surgical excision group saw a failure rate of 98.2%.

Imiquimod cream is a safe, effective, first-line alternative to surgery for the treatment of vulvar high-grade squamous intraepithelial lesions (vHSILs), suggest the results from the first ...

This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod. This combination showed promising results in topically accessible ...

El dermatólogo de Lüdenscheid, Andreas Jesper, toma con cautela el éxito en el tratamiento del cáncer de piel y recomienda el uso de la crema Imiquimod solamente después de que se haya ...

HealthDay News — For superficial or nodular basal cell carcinoma at low-risk sites, imiquimod has lower treatment success rates than surgery but the benefit is sustained at five years ...

Please provide your email address to receive an email when new articles are posted on . Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of ...

It is likely that in non-responder patients, the CD4+ T cells secrete more IL10 in response to Imiquimod application, prevent the generation of CD4 and CD8 effector T cells that are able to ...

The aim of this study was to evaluate the potential of Imiquimod and the related compound S-27609 as adjuvants in association with an HER2/neu DNA vaccine in a transgenic murine model of HER2/neu ...

Imiquimod (Aldara, R-837, S26308), the best characterized and most widely used, is highly efficacious in the treatment of external genital and anal warts, basal cell carcinoma, actinic keratoses ...